ORCHARD THERAPEUTICS PLC Operating Income
ORCHARD THERAPEUTICS PLC reported Operating Income of -$21.61 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC operating income (loss) for the quarter ending 2023-09-30 was -$21.61M.
- ORCHARD THERAPEUTICS PLC operating income (loss) for the quarter ending 2023-06-30 was -$22.56M.
- ORCHARD THERAPEUTICS PLC operating income (loss) for the quarter ending 2023-03-31 was -$26.26M.
- ORCHARD THERAPEUTICS PLC operating income (loss) for the quarter ending 2022-12-31 was -$31.59M.
- ORCHARD THERAPEUTICS PLC operating income (loss) for fiscal 2022 was -$127.09M.
- ORCHARD THERAPEUTICS PLC operating income (loss) for fiscal 2021 was -$140.43M.
- ORCHARD THERAPEUTICS PLC operating income (loss) for fiscal 2020 was -$156.98M.
- ORCHARD THERAPEUTICS PLC operating income (loss) for fiscal 2019 was -$172.87M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$21.61M 10-Q · filed 2023-11-13 | -$44.17M derived: sum of 2 quarters · filed 2023-11-13 | -$70.42M 10-Q · filed 2023-11-13 | -$102.02M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -$22.56M 10-Q · filed 2023-08-10 | -$48.82M 10-Q · filed 2023-08-10 | -$80.41M derived: sum of 3 quarters · filed 2023-08-10 | -$105.88M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | -$26.26M 10-Q · filed 2023-05-15 | -$57.85M derived: sum of 2 quarters · filed 2023-05-15 | -$83.32M derived: sum of 3 quarters · filed 2023-11-13 | -$115.77M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | -$31.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$57.06M derived: sum of 2 quarters · filed 2023-11-13 | -$89.51M derived: sum of 3 quarters · filed 2023-11-13 | -$127.09M 10-K · filed 2023-03-14 |
| 2022-09-30 | -$25.47M 10-Q · filed 2023-11-13 | -$57.92M derived: sum of 2 quarters · filed 2023-11-13 | -$95.50M 10-Q · filed 2023-11-13 | -$131.91M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$32.45M 10-Q · filed 2023-08-10 | -$70.03M 10-Q · filed 2023-08-10 | -$106.44M derived: sum of 3 quarters · filed 2023-08-10 | -$139.36M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$37.58M 10-Q · filed 2023-05-15 | -$74.00M derived: sum of 2 quarters · filed 2023-05-15 | -$106.91M derived: sum of 3 quarters · filed 2023-05-15 | -$142.93M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$36.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$69.33M derived: sum of 2 quarters · filed 2023-03-14 | -$105.35M derived: sum of 3 quarters · filed 2023-03-14 | -$140.43M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$32.92M 10-Q · filed 2022-11-14 | -$68.93M derived: sum of 2 quarters · filed 2022-11-14 | -$104.02M 10-Q · filed 2022-11-14 | -$142.89M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$36.01M 10-Q · filed 2022-08-04 | -$71.10M 10-Q · filed 2022-08-04 | -$109.97M derived: sum of 3 quarters · filed 2022-08-04 | -$136.28M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$35.09M 10-Q · filed 2022-05-12 | -$73.96M derived: sum of 2 quarters · filed 2022-05-12 | -$100.26M derived: sum of 3 quarters · filed 2022-05-12 | -$147.08M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$38.87M 10-K · filed 2021-03-02 | -$65.18M derived: sum of 2 quarters · filed 2021-11-04 | -$112.00M derived: sum of 3 quarters · filed 2021-11-04 | -$156.98M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$26.30M 10-Q · filed 2021-11-04 | -$73.12M derived: sum of 2 quarters · filed 2021-11-04 | -$118.11M 10-Q · filed 2021-11-04 | -$167.13M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$46.82M 10-Q · filed 2021-08-04 | -$91.80M 10-Q · filed 2021-08-04 | -$140.83M derived: sum of 3 quarters · filed 2021-08-04 | -$182.24M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | -$44.98M 10-Q · filed 2021-05-13 | -$94.01M derived: sum of 2 quarters · filed 2021-05-13 | -$135.42M derived: sum of 3 quarters · filed 2021-05-13 | -$189.57M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$49.03M 10-K · filed 2021-03-02 | -$90.44M derived: sum of 2 quarters · filed 2021-03-02 | -$144.59M derived: sum of 3 quarters · filed 2021-03-02 | -$172.87M 10-K · filed 2021-03-02 |
| 2019-09-30 | -$41.41M 10-K · filed 2021-03-02 | -$95.56M derived: sum of 2 quarters · filed 2021-03-02 | -$123.85M 10-Q · filed 2020-11-03 | -$152.68M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | -$54.15M 10-K · filed 2021-03-02 | -$82.44M 10-Q · filed 2020-08-06 | -$111.27M derived: sum of 3 quarters · filed 2021-03-02 | -$145.36M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | -$28.28M 10-K · filed 2021-03-02 | -$57.11M derived: sum of 2 quarters · filed 2021-03-02 | -$91.20M derived: sum of 3 quarters · filed 2021-03-02 | -$249.62M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-31 | -$28.83M 10-K · filed 2020-02-27 | -$62.92M derived: sum of 2 quarters · filed 2020-02-27 | -$221.33M derived: sum of 3 quarters · filed 2020-02-27 | -$235.03M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$34.09M 10-K · filed 2020-02-27 | -$192.50M derived: sum of 2 quarters · filed 2020-02-27 | -$206.20M 6-K · filed 2019-11-07 | |
| 2018-06-30 | -$158.41M 10-K · filed 2020-02-27 | -$172.11M 6-K · filed 2019-08-08 | ||
| 2018-03-31 | -$13.70M 10-K · filed 2020-02-27 | |||
| 2017-12-31 | -$38.51M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | -$19.20M 20-F · filed 2019-03-22 |